South Korean vaccine company SK Bioscience said it has prevailed in a lawsuit brought by Pfizer that accused it of infringing on the patent for the drugmaker's Prevnar 13 vaccine.

In a landmark decision that challenges the European Commission’s transparency standards, the General Court of the European ...

A ruling by the EU’s top court over undisclosed vaccine deal messages casts a shadow over Ursula von der Leyen’s presidency ...

The EU Court ruled against the Commission for failing to justify its refusal to release texts between von der Leyen and ...

A top European court says the European Commission failed to provide a credible explanation for refusing The New York Times ...

BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...

A top court Wednesday ruled the European Commission failed the transparency test by declining to release text messages sent ...

Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...

Pfizer is actively addressing these challenges through strategic acquisitions and cost efficiencies. The $43 billion acquisition of Seagen in 2023 bolsters its oncology portfolio, adding antibody ...

The firm behind Wikipedia has launched a legal challenge against the Online Safety Act, warning the specific requirements it could place on the platform would allow more online vandalism and ...